- Home
- AQST vs SSYS Comparison
AQST vs SSYS Comparison
Compare AQST & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- SSYS
- Stock Information
- Founded
- AQST 2004
- SSYS 1989
- Country
- AQST United States
- SSYS United States
- Employees
- AQST N/A
- SSYS N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- AQST Health Care
- SSYS Technology
- Exchange
- AQST Nasdaq
- SSYS Nasdaq
- Market Cap
- AQST 809.3M
- SSYS 970.9M
- IPO Year
- AQST 2018
- SSYS 1994
- Fundamental
- Price
- AQST $6.99
- SSYS $12.43
- Analyst Decision
- AQST Strong Buy
- SSYS Strong Buy
- Analyst Count
- AQST 7
- SSYS 3
- Target Price
- AQST $10.71
- SSYS $14.33
- AVG Volume (30 Days)
- AQST 3.6M
- SSYS 994.6K
- Earning Date
- AQST 10-31-2025
- SSYS 11-12-2025
- Dividend Yield
- AQST N/A
- SSYS N/A
- EPS Growth
- AQST N/A
- SSYS N/A
- EPS
- AQST N/A
- SSYS N/A
- Revenue
- AQST $44,132,000.00
- SSYS $564,499,000.00
- Revenue This Year
- AQST N/A
- SSYS N/A
- Revenue Next Year
- AQST $51.50
- SSYS $3.06
- P/E Ratio
- AQST N/A
- SSYS N/A
- Revenue Growth
- AQST N/A
- SSYS N/A
- 52 Week Low
- AQST $2.12
- SSYS $6.92
- 52 Week High
- AQST $7.55
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- AQST 63.34
- SSYS 63.03
- Support Level
- AQST $6.78
- SSYS $10.85
- Resistance Level
- AQST $7.55
- SSYS $12.27
- Average True Range (ATR)
- AQST 0.41
- SSYS 0.61
- MACD
- AQST 0.04
- SSYS 0.07
- Stochastic Oscillator
- AQST 71.13
- SSYS 85.29
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.